In the course of device testing, the firm determined that the affected devices may, under certain unusual
clinical circumstance, be unable to generate a therapeutic dose of radio frequency energy. As such,
for these few devices, the effectiveness of Provant therapy may be impaired.
Source facts
Action
Written notification dated September 29, 2008 was sent to consignees by overnight mail notifying them of the nonconformance and providing instructions for return of the affected PROVANT Model 4201A units to Regenesis. Receipt of the notification and return shipping of the units will be verified. Contact Regenesis Biomedical Inc. for additional information at 1-480-970-4970.
Initiated
2008-09-29
Root cause
Finished device change control
Terminated
2009-07-08
Distribution
WY, VA, and NC
Recall number
Z-0887-2009
Recall status
Terminated
CDRH record ID
75023
FDA classified
2009-01-26
Recall event number
50230
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.